Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -36,472 | N/A | N/A | N/A |
| Depreciation Amortization | N/A | 5,070 | N/A | N/A | N/A |
| Accounts receivable | N/A | -31 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 1,231 | N/A | N/A | N/A |
| Other Working Capital | N/A | 32,421 | N/A | N/A | N/A |
| Other Operating Activity | -8,398 | -24,299 | -18,956 | -11,256 | -4,761 |
| Operating Cash Flow | $-8,398 | $-22,080 | $-18,956 | $-11,256 | $-4,761 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,068 | -12,582 | -7,504 | -4,417 | -2,807 |
| Investing Cash Flow | $-1,068 | $-12,582 | $-7,504 | $-4,417 | $-2,807 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | 24,000 | N/A | 20,000 | 20,000 |
| Debt Repayment | -630 | -2,367 | -1,630 | -1,161 | -560 |
| Common Stock Issued | 253 | 22,159 | 41,425 | 476 | 243 |
| Other Financing Activity | 0 | 500 | 500 | 0 | 0 |
| Financing Cash Flow | $3,623 | $44,292 | $40,295 | $19,315 | $19,683 |
| Beginning Cash Position | 12,329 | 2,699 | 2,699 | 2,699 | 2,699 |
| End Cash Position | 6,486 | 12,329 | 16,534 | 6,341 | 14,814 |
| Net Cash Flow | $-5,843 | $9,630 | $13,835 | $3,642 | $12,115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,398 | -22,080 | -18,956 | -11,256 | -4,761 |
| Capital Expenditure | -1,068 | -12,582 | -7,504 | -4,417 | -2,807 |
| Free Cash Flow | -9,466 | -34,662 | -26,460 | -15,673 | -7,568 |